Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Conclusion: Tio/Olo significantly improved FEV1.0 compared with Tio in patients with treatment naive COPD. Both Tio/Olo and Tio decreased the amount of time spent in the sedentary position, and increased the duration of ≥ 2.0 METs PA.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Takahashi, K., Uchida, M., Kato, G., Takamori, A., Sadamatsu, H., Tanaka, M., Tajiri, R., Kinoshita, T., Kojima, K., Yoshida, M., Tashiro, H., Hayashi, S., Kawaguchi, A., Sueoka-Aragane, N., Kawayama, T. Tags: Airway pharmacology and treatment Source Type: research
More News: Chronic Obstructive Pulmonary | Drugs & Pharmacology | Respiratory Medicine | Spiriva | Study | Tiotropium